Literature DB >> 20405301

Is polymyositis or dermatomyositis in patients with rheumatoid arthritis induced or unveiled by anti-tumor necrosis factor treatment?

Takao Nagashima, Seiji Minota.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20405301     DOI: 10.1007/s10067-010-1467-6

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


× No keyword cloud information.
  10 in total

1.  Clinical and serological aspects of patients with anti-Jo-1 antibodies--an evolving spectrum of disease manifestations.

Authors:  W A Schmidt; W Wetzel; R Friedländer; R Lange; H F Sörensen; H J Lichey; E Genth; R Mierau; E Gromnica-Ihle
Journal:  Clin Rheumatol       Date:  2000       Impact factor: 2.980

2.  Association of polymyositis with rheumatoid arthritis.

Authors:  E Martínez-Cordero; D E León; L A Ortega
Journal:  Rheumatol Int       Date:  2001-04       Impact factor: 2.631

3.  Antisynthetase syndrome associated with long-standing rheumatoid arthritis.

Authors:  Takao Nagashima; Masahiro Iwamoto; Seiji Minota
Journal:  Rheumatol Int       Date:  2010-03-30       Impact factor: 2.631

4.  Evolution of antinuclear antibodies and clinical patterns in patients with active rheumatoid arthritis with longterm infliximab therapy.

Authors:  Elisabeth Comby; Pascale Tanaff; Delphine Mariotte; Valerie Costentin-Pignol; Christian Marcelli; Jean Jacques Ballet
Journal:  J Rheumatol       Date:  2006-01       Impact factor: 4.666

5.  Polymyositis associated with infliximab treatment for rheumatoid arthritis.

Authors:  Yukitomo Urata; Yuji Wakai; Kenji Kowatari; Taisuke Nitobe; Yutaka Mizushima
Journal:  Mod Rheumatol       Date:  2006-12-20       Impact factor: 3.023

Review 6.  Polymyositis, pulmonary fibrosis and autoantibodies to aminoacyl-tRNA synthetase enzymes.

Authors:  C Marguerie; C C Bunn; H L Beynon; R M Bernstein; J M Hughes; A K So; M J Walport
Journal:  Q J Med       Date:  1990-10

7.  Dermatomyositis associated with thyroid cancer: a paraneoplastic syndrome?

Authors:  Takao Nagashima; Sachiko Onishi; Yasuyuki Kamata; Seiji Minota
Journal:  Rheumatol Int       Date:  2009-01-14       Impact factor: 2.631

8.  Neuromuscular involvement in rheumatic patients treated with anti-tumor necrosis factor therapy--three examples.

Authors:  Uta Kiltz; Claas Fendler; Jurgen Braun
Journal:  J Rheumatol       Date:  2008-10       Impact factor: 4.666

9.  Etanercept-induced anti-Jo-1-antibody-positive polymyositis in a patient with rheumatoid arthritis: a case report and review of the literature.

Authors:  Yuki Ishikawa; Naoichiro Yukawa; Koichiro Ohmura; Yuji Hosono; Yoshitaka Imura; Daisuke Kawabata; Takaki Nojima; Takao Fujii; Takashi Usui; Tsuneyo Mimori
Journal:  Clin Rheumatol       Date:  2010-02-09       Impact factor: 2.980

10.  Autoimmune diseases induced by TNF-targeted therapies: analysis of 233 cases.

Authors:  Manuel Ramos-Casals; Pilar Brito-Zerón; Sandra Muñoz; Natalia Soria; Diana Galiana; Laura Bertolaccini; Maria-Jose Cuadrado; Munther A Khamashta
Journal:  Medicine (Baltimore)       Date:  2007-07       Impact factor: 1.889

  10 in total
  2 in total

1.  Is dermatomyositis in patients with rheumatoid arthritis induced by anti-TNF-α therapy?

Authors:  Alexandra Maria Giovanna Brunasso; Cesare Massone
Journal:  Clin Rheumatol       Date:  2011-01-11       Impact factor: 2.980

2.  Moderate incidence of prior rheumatoid arthritis in patients with polymyositis and dermatomyositis.

Authors:  Takao Nagashima; Masahiro Iwamoto; Seiji Minota
Journal:  Clin Rheumatol       Date:  2011-04-27       Impact factor: 2.980

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.